Thilo Schroeder, a Partner (also identified as Managing Partner) at Nextech Invest. See sector focus and contact routes.
Thilo Schroeder, a Partner (also identified as Managing Partner) at Nextech Invest, invests exclusively in precision oncology and cancer therapeutics across stages from seed and early venture to late-stage growth and crossover rounds. His notable portfolio includes Revolution Medicines, Peloton Therapeutics, Blueprint Medicines, IDEAYA Bioscience, Neon Therapeutics, and Kura Oncology. Schroeder’s distinctive thesis centers on backing drug discovery companies with the potential to create multiple medicines and requiring evidence of efficacy in preclinical animal models before investing.
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Zürich.
Investors like Thilo Schroeder · Full investor directory · Investor access · Company funding database